Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference83 articles.
1. •• Khoury JD, Wang WL, Prieto VG, et al. Validation of immunohistochemical assays for integral biomarkers in the NCI-MATCH EAY131 clinical trial. Clin Cancer Res. 2018;24:521–31 This paper describes in detail principles of immunohistochemistry validation in the context of integral biomarkers used for therapy selection in a large national clinical trial.
2. Loghavi S, Al-Ibraheemi A, Zuo Z, et al. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. Br J Haematol. 2015;171:91–9.
3. Kurt H, Bueso-Ramos CE, Khoury JD, Routbort MJ, Kanagal-Shamanna R, Patel UV, et al. Characterization of IDH1 p.R132H mutant clones using mutation-specific antibody in myeloid neoplasms. Am J Surg Pathol. 2018;42:569–77.
4. Coons A, Creech H, Jones R. Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med. 1941;47:200–2.
5. Taylor CR. An exaltation of experts: concerted efforts in the standardization of immunohistochemistry. Hum Pathol. 1994;25:2–11.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献